论文部分内容阅读
Phase Ⅲ, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non
【作 者】
:
【机 构】
:
HospitalUniversitarioDocedeOctubre,Sevilla,SpainVanderbilt-IngramCancerCenter,Nashville,TNFoxChaseCa
【出 处】
:
2015年临床肿瘤学新进展学术研讨会
【发表日期】
:
2015年7期
其他文献
Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast can
会议
Randomized phase Ⅱ study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts
会议
SIRFLOX Randomized phase Ⅲ trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 +
会议
PET-NECK A multi-centre, randomized, phase Ⅲ, controlled trial (RCT) comparing PETCT guided active s
会议
Phase Ⅲ randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS
会议
NCCTG N0574 (Alliance) A phase Ⅲ randomized trial of whole brain radiation therapy (WBRT) in additio
会议